FBM-30244-28415
2 vaccinations
4 coded responses
9 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 774 / TX
- Registered
- 2021-04-05
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-04-05
Registered in v-safe
-
2021-04-05
Dose 1 — Pfizer-BioNTech
- 2021-04-06
- 2021-04-07
- 2021-04-08
-
2021-04-10
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-04-26
Dose 2 — Pfizer-BioNTech
- 2021-05-03
-
2021-06-04
Survey response — day 35, dose 2MedDRA: Abdominal discomfort, Cough, Fatigue, Oropharyngeal pain, Respiratory tract congestion — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Fatigue, cough, congestion, sore throat, gastric upsetMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-09
Survey response — day 42, dose 2MedDRA: Fatigue, Myalgia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Muscle aches and fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-27
Survey response — 3 months, dose 2MedDRA: Hypersensitivity, Sinus disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Increased sinus and allergy sensitivityMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-04-28
Survey response — 12 months, dose 2MedDRA: Brain fog, Fatigue — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Constant fatigue and brain fog.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-28
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-05 | Pfizer-BioNTech | |
| 2 | 2021-04-26 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — day 35, dose 2
Symptoms: Fatigue, cough, congestion, sore throat, gastric upset
Release 9 — day 42, dose 2
Symptoms: Muscle aches and fatigue
Release 9 — 3 months, dose 2
Symptoms: Increased sinus and allergy sensitivity
Release 11 — 12 months, dose 2
Symptoms: Constant fatigue and brain fog.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | ✓ | ✓ | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | ✓ | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Sinus disorder | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release